Single-chain Fragment variable antibody targeting cholecystokinin-B receptor for pain reduction
{{output}}
The cholecystokinin B receptor and its neuropeptide ligand are upregulated in chronic neuropathic pain models. Single-chain Fragment variable antibodies were generated as preferred non-opioid targeting therapy blocking the cholecystokinin B receptor to inhibit... ...
